Clinical Trial Update: REcommened Communication With Sympathy in Terminally Ill Cancer Patients Treated With Palliative Sedation [Phase 2]

View source ↗

Summary

Phase 2 trial update on recommended communication with sympathy for terminally ill cancer patients receiving palliative sedation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Communication, Palliative Sedation | Phase 2 | Status: UNKNOWN